BioSpace News Archive

Edward Mueller assumes role as independent chair of McKesson’s Board of Directors

The meeting will be held March 29 – April 3, 2019, at the Georgia World Congress Center in Atlanta, Georgia.

Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet patient needs, today announced that the Marketing Authorisation Application (MAA) for its investigational agent, HTX-011,

Amneal Pharmaceuticals, Inc. (NYSE: AMRX), today announced that it has entered into an agreement with Zentiva Group a.s., under which Zentiva has acquired Creo Pharmaceuticals Ltd., a subsidiary of Amneal that operates the company’s commercial operations in the United Kingdom.

Expects to commence the global Phase 3 pivotal trial of mavorixafor for the treatment of patients with Warts, Hypogammaglobulinemia, Infections and Myelokathexis syndrome in second quarter 2019 having finalized the protocol based on FDA guidance

Interested parties can access the conference call by dialing 844-634-1444 within the U.S. and Canada, or 1-615-247-0253 internationally, using the passcode 7459328.

Solidifies a Leading Position in California, the World’s Largest Regulated Cannabis Market

Cibus, a leader in advanced plant-breeding technologies, today announced it has licensed to Valley Oils Partners certain U.S. rights to cultivate canola with the Cibus ultra-high-oleic oil trait.

David Peterson joins AccuReg with more than 20 years of healthcare and technology marketing experience

Studies offer insights on development, prevention and treatment of leading diseases